Allspring Global Investments
HCAT icon

Allspring Global Investments’s Health Catalyst HCAT Stock Holding History

Allspring Global Investments’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,272
Closed -$14.5K – 2520
2024
Q2 		$14.5K Buy
+2,272
New +$14.6K ﹤0.01% 2168
2023
Q4 		– Sell
-2,146
Closed -$21.7K – 2438
2023
Q3 		$21.7K Buy
+2,146
New +$25.6K ﹤0.01% 2495
2022
Q2 		– Sell
-10,442
Closed -$272K – 2787
2022
Q1 		$272K Buy
10,442
+646
+7% +$18.3K ﹤0.01% 2467
2021
Q4 		$388K Buy
+9,796
New +$446K ﹤0.01% 2402

Other funds holding HCAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return